Moreover, macrophages and CCL2 were correlated with each other and with poor survival in ER+ patients; it was also found that monocytic cells cultured with CM of tamoxifen-resistant luminal-A cells secreted elevated levels of CCL2, which then acted directly on BC cells to increase endocrine resistance via the PI3K/AKT/mTOR pathway (127). This evidence concerns the gene CCL2 and breast cancer.